Nothing Special   »   [go: up one dir, main page]

Kinoshita et al., 2011 - Google Patents

Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved

Kinoshita et al., 2011

View PDF
Document ID
10621902213454560782
Author
Kinoshita Y
Fujii H
Takeshita A
Taguchi M
Miyakawa M
Oyama K
Yamada S
Takeuchi Y
Publication year
Publication venue
European journal of endocrinology

External Links

Snippet

Objective Impaired glucose metabolism is common in acromegaly, but it is not clear how glucose metabolism is impaired or what predicts its restoration after cure of the disease. To identify factors involved in the impairment of glucose metabolism in acromegaly, we …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Similar Documents

Publication Publication Date Title
Kinoshita et al. Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved
Martin et al. Genetic evidence for different adiposity phenotypes and their opposing influences on ectopic fat and risk of cardiometabolic disease
Fieffe et al. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
Lam et al. Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community
Urbani et al. Effects of medical therapies for acromegaly on glucose metabolism
Chakkera et al. Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus
Melton III et al. A bone structural basis for fracture risk in diabetes
Neggers et al. Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients
Lastya et al. The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus
Hofsø et al. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
Hong et al. Acromegaly and cardiovascular outcomes: a cohort study
Nolan et al. Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes
Shim et al. Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes
Yoshida et al. Ketoacidosis as the initial clinical condition in nine patients with acromegaly: a review of 860 cases at a single institute
Yamazaki et al. Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers
Lv et al. Identification of reactive hypoglycemia with different basic BMI and its causes by prolonged oral glucose tolerance test
Roy Chowdhury et al. Diabetic retinopathy in newly diagnosed subjects with type 2 diabetes mellitus: contribution of β-cell function
Zhou et al. Assessing 1-h plasma glucose and shape of the glucose curve during oral glucose tolerance test
Rasouli et al. Association of baseline characteristics with insulin sensitivity and β-cell function in the glycemia reduction approaches in diabetes: a comparative effectiveness (GRADE) study cohort
Atquet et al. Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load
Lindsay et al. Rate of gestational weight gain and glucose-insulin metabolism among Hispanic pregnant women with overweight and obesity
Meyer et al. Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients
Wang et al. Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk
Jeun et al. Clinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center
Rozing et al. C-reactive protein and glucose regulation in familial longevity